EDRN Gastrointestinal Cancers Collaborative Group

Tuesday, September 24, 2024 (2:30 p.m. to 5:45 p.m.)

Room: College of Nursing, Room 2017

Chair: Cecilia Yeung, MD, Fred Hutchinson Cancer Center

Acting Chair: Robert Bresalier, MD., MD Andersen Medical Center

DMCC Statisticians: Ziding Feng, PhD, and Ying Huang, PhD, Fred Hutchinson Cancer Research Center

DMCC Staff: Stephanie Page-Lester, Fred Hutchinson Cancer Center

NCI Program Director: Matthew Young, PhD, National Cancer Institute

Agenda

Central Daylight Time Agenda Item

2:30 p.m. – 2:45 p.m.

Welcome/Elect New Chair

  • Cecilia Yeung, MD, Fred Hutchinson Cancer Center
  • Robert Bresalier, MD, MD Andersen Medical Center

2:45 p.m. – 3:20 p.m.

Host Presentations (University of Nebraska Medical Center):

2:45 p.m. – 3:00 p.m.

Carbohydrate-based Biomarkers, We’ve Come a Long Way

01: Surinder Batra, PhD, University of Nebraska College of Medicine

3:00 p.m. – 3:15 p.m.

Early-Stage Investigator Presentation: Novel Reagents and Assays for Evaluating MUC5AC as a Biomarker for Detection and Management of Pancreatic Cancer

02: Abhijit Aithal, PhD, University of Nebraska Medical Center

3:15 p.m. – 3:20 p.m.

Q&A

3:20 p.m. – 4:45 p.m.

Collaborative Groups and Industrial Partner Collaboration

3:20 p.m. – 3:35 p.m.

EDRN Collaborative Group Validation of Plasma Biomarkers that Increase Sensitivity and Specificity Over CA19-9 Alone for Detection of Resectable PDAC

03: Brian Haab, PhD., Van Andel Institute

3:35 p.m. – 3:50 p.m.

Blood-based Biomarkers for Risk Assessment of Pancreatic Cancer

04: Johannes Fahrmann, PhD, The University of Texas MD Anderson Cancer Center

3:50 p.m. – 4:05 p.m.

Cancer-Macrophage Hybrid Cells in Blood of Gastrointestinal Cancer Patients Correlates with Poor Outcomes

05: Cha-Mei Tang, ScD, President and CEO, Creatv MicroTech,

4:05 p.m. – 4:20 p.m.

Novel Class of Bacterial Biomarkers with Utility for Earlier Diagnosis of Colorectal Cancer from Fecal Samples

06: Mark Driscoll, PhD., Intus Biosciences, CSO

4:20 p.m. – 4:45 p.m.

Q&A

4:45 p.m. – 5:20 p.m.

Updates from EDRN Principal Investigators (5 minutes, 1 slide)

4:45 p.m. – 4:50 p.m.

07: William Grady, MD, Fred Hutchinson Cancer Center (BCC)

4:50 p.m. – 4:55 p.m.

08: Robert Bresalier, MD, The University of Texas MD Anderson Cancer Center (CVC)

4:55 p.m. – 5:00 p.m.

09: Randall Brand, MD, University of Pittsburgh (CVC)

5:00 p.m. – 5:05 p.m.

10: Jorge Marrero, MD, MS, University of Pennsylvania Health System (CVC)

5:05 p.m. – 5:10 p.m.

11: Johannes Fahrmann, PhD, The University of Texas MD Anderson Cancer Center (CVC)

5:10 p.m. – 5:15 p.m.

12: Robert Schoen, MD, MPH, University of Pittsburgh (CVC)

5:15 p.m. – 5:20 p.m.

13: Sanford Markowitz, MD, PhD, Case Western Reserve University (CVC)

5:20 p.m. – 5:45 p.m.

Chair Discussion

5:45 p.m.

Adjourn